IL109164A0 - Purification of factor VII - Google Patents

Purification of factor VII

Info

Publication number
IL109164A0
IL109164A0 IL10916494A IL10916494A IL109164A0 IL 109164 A0 IL109164 A0 IL 109164A0 IL 10916494 A IL10916494 A IL 10916494A IL 10916494 A IL10916494 A IL 10916494A IL 109164 A0 IL109164 A0 IL 109164A0
Authority
IL
Israel
Prior art keywords
purification
factor vii
vii
factor
Prior art date
Application number
IL10916494A
Other languages
English (en)
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of IL109164A0 publication Critical patent/IL109164A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6437—Coagulation factor VIIa (3.4.21.21)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21021—Coagulation factor VIIa (3.4.21.21)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Peptides Or Proteins (AREA)
  • Catalysts (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL10916494A 1993-03-31 1994-03-30 Purification of factor VII IL109164A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK93382A DK38293D0 (da) 1993-03-31 1993-03-31 Fremstilling af proteiner

Publications (1)

Publication Number Publication Date
IL109164A0 true IL109164A0 (en) 1994-06-24

Family

ID=8092871

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10916494A IL109164A0 (en) 1993-03-31 1994-03-30 Purification of factor VII

Country Status (16)

Country Link
US (1) US5700914A (member.php)
EP (1) EP0691984A1 (member.php)
JP (1) JPH08508264A (member.php)
CN (1) CN1039231C (member.php)
AU (1) AU677309B2 (member.php)
CA (1) CA2159313A1 (member.php)
CZ (1) CZ253395A3 (member.php)
DK (1) DK38293D0 (member.php)
FI (1) FI954649A7 (member.php)
HU (1) HUT72712A (member.php)
IL (1) IL109164A0 (member.php)
NO (1) NO953883L (member.php)
PL (1) PL310887A1 (member.php)
TW (1) TW278079B (member.php)
WO (1) WO1994022905A1 (member.php)
ZA (1) ZA941956B (member.php)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19538716A1 (de) * 1995-10-18 1997-04-24 Behringwerke Ag Verfahren zur Quantifizierung von aktiviertem Gerinnungsfaktor VII (FVIIa)
DE19538715A1 (de) 1995-10-18 1997-04-30 Behringwerke Ag Verfahren zur Reinigung von Faktor VII und aktiviertem Faktor VII
AU760048B2 (en) 1998-05-06 2003-05-08 Genentech Inc. Protein purification by ion exchange chromatography
AT408613B (de) 1998-06-17 2002-01-25 Immuno Ag Pharmazeutisches faktor vii-präparat
NZ521257A (en) 2000-02-11 2004-10-29 Maxygen Aps Factor VII or VIIa-like molecules
BR0215216A (pt) 2001-12-21 2004-11-16 Novo Nordisk Healthcare Ag Composição aquosa lìquida, método para preparar uma composição aquosa lìquida de um polipeptìdeo de fator vii, uso de uma composição aquosa lìquida, e, método para o tratamento de uma sìndrome de resposta ao fator vii
US20040009918A1 (en) * 2002-05-03 2004-01-15 Hanne Nedergaard Stabilised solid compositions of modified factor VII
KR20050013148A (ko) * 2002-06-21 2005-02-02 노보 노르디스크 에이/에스 인자 ⅶ 폴리펩티드의 안정화된 고체 조성물
MXPA05009770A (es) * 2003-03-18 2005-11-17 Novo Nordisk Healthcare Ag Metodo para la produccion de serina proteasas que contienen residuos de gla.
US7897734B2 (en) 2003-03-26 2011-03-01 Novo Nordisk Healthcare Ag Method for the production of proteins
CN1780638B (zh) 2003-05-23 2010-04-14 诺和诺德医疗保健公司 氧化硅涂层玻璃作为容器内壁材料的用途及以该材料作内壁的容器
WO2004112828A1 (en) * 2003-06-25 2004-12-29 Novo Nordisk Health Care Ag Liquid composition of factor vii polypeptides
JP5306597B2 (ja) * 2003-07-01 2013-10-02 ノボ ノルディスク ヘルス ケア アクチェンゲゼルシャフト 第ｖｉｉ因子ポリペプチドの液体水性薬学的組成物
JP5653572B2 (ja) 2003-08-14 2015-01-14 ノボ ノルディスク ヘルス ケア アクチェンゲゼルシャフト 第ｖｉｉ因子ポリペプチドの液状水性医薬組成物
ES2926359T3 (es) 2003-12-01 2022-10-25 Novo Nordisk Healthcare Ag Filtración de virus de composiciones líquidas del Factor VII
ATE507822T1 (de) * 2003-12-19 2011-05-15 Novo Nordisk Healthcare Ag Stabilisierte zusammensetzungen von faktor-vii- polypeptiden
WO2006067230A1 (en) * 2004-12-23 2006-06-29 Novo Nordisk Health Care Ag Reduction of the content of protein contaminants in compositions comprising a vitamin k-dependent protein of interest
US20090047723A1 (en) * 2005-01-14 2009-02-19 Bayer Healthcare Llc Method for purification of factor vii
EP1907540B1 (en) * 2005-07-22 2012-12-19 Bayer HealthCare LLC In-solution activation of factor vii
ES2779992T3 (es) * 2005-12-20 2020-08-21 Univ Duke Métodos y composiciones para suministrar agentes activos con propiedades farmacológicas potenciadas
US20130172274A1 (en) 2005-12-20 2013-07-04 Duke University Methods and compositions for delivering active agents with enhanced pharmacological properties
US8841255B2 (en) 2005-12-20 2014-09-23 Duke University Therapeutic agents comprising fusions of vasoactive intestinal peptide and elastic peptides
CA2953975C (en) 2008-06-27 2019-11-26 Duke University Therapeutic agents comprising elastin-like peptides
CN103539852B (zh) * 2012-07-12 2015-08-12 上海泰龙生物医药科技有限公司 一种从细胞培养液中分离纯化重组人凝血八因子的方法
EP2687595B1 (en) * 2012-07-19 2018-05-30 Laboratoire Français du Fractionnement et des Biotechnologies Method for purifying transgenic factor VII
US10285915B2 (en) 2012-10-17 2019-05-14 The Procter & Gamble Company Strip for the delivery of an oral care active and methods for applying oral care actives
EP3560946B1 (en) * 2016-12-22 2022-02-02 KM Biologics Co., Ltd. Chromatographic method for collecting blood coagulation factor vii with high yield

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4981952A (en) * 1988-10-04 1991-01-01 Eli Lilly And Company Method for the purification of vitamin K-dependent proteins

Also Published As

Publication number Publication date
HU9502846D0 (en) 1995-12-28
CZ253395A3 (en) 1996-01-17
US5700914A (en) 1997-12-23
CA2159313A1 (en) 1994-10-13
WO1994022905A1 (en) 1994-10-13
EP0691984A1 (en) 1996-01-17
AU6423994A (en) 1994-10-24
CN1039231C (zh) 1998-07-22
HUT72712A (en) 1996-05-28
FI954649A0 (fi) 1995-09-29
ZA941956B (en) 1994-09-30
FI954649L (fi) 1995-09-29
NO953883L (no) 1995-11-28
TW278079B (member.php) 1996-06-11
AU677309B2 (en) 1997-04-17
PL310887A1 (en) 1996-01-08
DK38293D0 (da) 1993-03-31
FI954649A7 (fi) 1995-09-29
NO953883D0 (no) 1995-09-29
CN1121723A (zh) 1996-05-01
JPH08508264A (ja) 1996-09-03

Similar Documents

Publication Publication Date Title
ZA941956B (en) Purification of factor VII
GB2274412B (en) Gas purification
ZA947090B (en) Purification of fluids by adsorption
GB2280858B (en) Water purifier with different degrees of purification
HU9302059D0 (en) Differentiating factor of megacaryocyte
GB9421247D0 (en) Purification of indigo
GB9210081D0 (en) Purification process
ZA932553B (en) New use of B-carbolines
GB9206667D0 (en) Purification process
ZA956809B (en) Purification of pentafluoroethane
EP0424316A3 (en) Purification of 2-aryl-2h-benzotriazoles
GB2275266A8 (en) Preparation of 2-methyl-3-aminobenzotrifluoride
ZA944577B (en) Preparation of aminopropionitriles
GB9417815D0 (en) Purification of pentafluoroethane
GB9300501D0 (en) Purification of immunoglobulin
HU9204061D0 (en) Purification method
GB9309400D0 (en) Purification of fluoronucleosides
ZA946619B (en) Production of diffluoromethane
GB9324912D0 (en) Purification of gases
GB9309453D0 (en) Polyester purification
GB9215562D0 (en) Purification of pentafluoroethane
GB9215563D0 (en) Purification of pentafluoroethane
PL299577A1 (en) Method of purifying manganese
GB9313575D0 (en) Preparation of solutions
PL55382Y1 (en) Set of symmetrisers